We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DexCom Inc | NASDAQ:DXCM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.28 | 1.00% | 129.65 | 129.04 | 129.77 | 129.94 | 127.79 | 128.66 | 1,858,417 | 00:27:58 |
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Quentin Blackford to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer.
Mr. Blackford has served as Dexcom’s Executive Vice President and Chief Financial Officer since 2017. He has played a key role during one of the most significant periods of growth in the Company’s history, including the launch of Dexcom’s G6 system and the ongoing expansion of the Company’s manufacturing and business service operations. In his new role as COO, Quentin will oversee Dexcom’s worldwide supply chain, manufacturing operations, and expansion into new markets, better positioning the Company to fulfill its growth potential.
“We believe we are on the cusp of tremendous opportunities that will require discipline across our financial investments, resource allocation and business processes,” said Kevin Sayer, Chairman, President and Chief Executive Officer at Dexcom. “In light of this, we are expanding Quentin’s role to include oversight of global manufacturing operations, supply chain management and expansion into new markets. We believe this expanded role will allow for better coordination across key business units that are critical to the realization of these opportunities.”
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190917006085/en/
DexCom, Inc.: Steven R. Pacelli Executive Vice President, Strategy and Corporate Development (858) 200-0200 www.dexcom.com
1 Year DexCom Chart |
1 Month DexCom Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions